# Crescent Capital BDC share price today (Crescent Capital BDC, Inc., CCAP)

> Crescent Capital BDC, Inc.'s P/BV is near the low end of its own history, higher than only 9% of past readings, and its quarterly results are still getting worse. CCAP · Financials · Asset Management · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/ccap

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $9.35 (−33.8% in a year)
- P/BV: 0.5× (lower than 91% of the last 1 year)
- Revenue (Jun 2026): $36.3 M (−15.5% on a year ago)
- Profit (Jun 2026): −$3.2 M (−121.6% on a year ago)
- Net margin: −8.9% (−43.8 points on a year ago)
- ROE: −1%, FY25
- ROA: 4.59%, latest

The main question: the P/BV is near the low end of its own history, higher than only 9% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. ## What is the Crescent Capital BDC share price today? Crescent Capital BDC, Inc.'s share price was $9.35 at the close on 3 November 2026. That is 19.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between $9 and $15, and at that close it sat 11% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 38 weeks running. Over the last 1 year the share price moved −37% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 13 February 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Crescent Capital BDC pay? Crescent Capital BDC, Inc. paid $1.60 per share over the last four reported quarters. The most recent declaration was $0.34 for Jun 2026. At today's price of $9.35 that is a yield of 17.11%, based on dividends already paid, not a forecast. ## Which stock lists is Crescent Capital BDC on? Crescent Capital BDC is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Crescent Capital BDC profitable? Crescent Capital BDC, Inc. posted a net loss of $3.2 M in the Jun 2026 quarter. Full-year FY25 profit was $34.5 M. Over 4 years profit has grown −19.9% a year on average. That loss is 8.9% of the quarter's revenue. The same quarter a year earlier earned $15.0 M. 2 of the last 12 reported quarters were loss-making. Jun 2026 profit was −$3.2 M, −121.6% on a year earlier. For the full year, FY25 profit was $34.5 M (−53.1% on the year before). Why profit moved: revenue changed −15.5% on a year earlier and the margin moved −43.8 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −171.9% and revenue −14.4%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Crescent Capital BDC make, and is it growing? Crescent Capital BDC, Inc. reported $36.3 M of income in the Jun 2026 quarter, −15.5% on the same quarter a year earlier. Over 4 years it has grown 15.5% a year on average. The last full year, FY25, came in at $167 M. The last four reported quarters add to $156 M. FY25 revenue was $167 M, −15.2% on the year before. Recent pace: the last four quarters grew −14.4% on average, against 15.5% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −14.6%, against −11.0% a year over the last 8 quarters (rolling over). ## How much does Crescent Capital BDC keep from what it earns? Crescent Capital BDC, Inc.'s net margin was −8.9% in the Jun 2026 quarter, 43.8 percentage points lower than the same quarter a year ago. Across 5 years it has been between 13.3% and 89.0%. The latest quarter is below every full year in that period. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Crescent Capital BDC's loans have gone bad? Crescent Capital BDC, Inc. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Crescent Capital BDC's loan book growing? Crescent Capital BDC, Inc.'s revenue was $167 M in FY25, −15.2% on the year before, so the loan book is not growing. The latest quarter was −15.5% on a year earlier. The net margin on that income is −8.9%, −43.8 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is Crescent Capital BDC's P/BV ratio, and how does it compare with its own history? Crescent Capital BDC, Inc.'s P/BV is 0.5×, near the low end of its own history: it has been lower only 9% of the time. Its usual P/BV (the middle reading) is 0.7×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is low: this lender earns about −1% a year on its equity. A lender that earns less on its net worth is valued lower for each dollar of it, and that gap usually closes only if returns improve. Why the multiple is where it is: over the past year book value grew while the price moved −33.8%. Price and book value moved together, so the multiple stayed in its range. In short: the multiple is low against its own past, so the book value trend underneath matters more than the multiple. ## Is the Crescent Capital BDC business getting better or worse? Crescent Capital BDC, Inc.'s business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −14.6% in the latest quarter, against +58.8% at its best in 12 quarters, with ROE falling at -0.5%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Crescent Capital BDC earn on its equity and assets? Crescent Capital BDC, Inc. earned a return on equity of 5% in FY25. Its lowest yearly reading on file was 3% in FY22. On its assets, every $100 earned about $4.59, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That return is below the level a bank needs to grow its net worth quickly, which helps explain why its multiple is where it is. Why ROE moved: profit grew −19.9% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low. ## Does Crescent Capital BDC have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Crescent Capital BDC shareholding pattern? We have no ownership or short-position figures for Crescent Capital BDC, Inc., so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 2.9 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is Crescent Capital BDC from balance-sheet trouble? For Crescent Capital BDC, Inc., the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Crescent Capital BDC rank in its industry? There is no score against its industry: Crescent Capital BDC, Inc. is not among the largest members shown in this industry comparison for Asset Management. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Crescent Capital BDC compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Crescent Capital BDC in size? Crescent Capital BDC is the 78th largest of 90 Asset Management companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: AlTi Global, Inc., BlackRock TCP Capital Corp. and Eagle Point Credit Company. Just below it: CION Investment Corporation, Kingsway Corporation and Runway Growth Finance Corp. ### Asset Management companies close in size

1. [AlTi Global, Inc.](https://www.sectoralpha.in/us/stocks/alti) $382 million
2. [BlackRock TCP Capital Corp.](https://www.sectoralpha.in/us/stocks/tcpc) $352 million
3. [Eagle Point Credit Company](https://www.sectoralpha.in/us/stocks/ecc) $350 million
4. Crescent Capital BDC, Inc. $345 million
5. [CION Investment Corporation](https://www.sectoralpha.in/us/stocks/cion) $336 million
6. [Kingsway Corporation](https://www.sectoralpha.in/us/stocks/kwy) $284 million
7. [Runway Growth Finance Corp.](https://www.sectoralpha.in/us/stocks/rway) $271 million

[All 90 Asset Management companies, largest first](https://www.sectoralpha.in/us/sectors/asset-management#all-companies)

### Companies close in size in other industries

1. [ClearPoint Neuro, Inc.](https://www.sectoralpha.in/us/stocks/clpt) $342 million · Medical Devices
2. [CapsoVision, Inc.](https://www.sectoralpha.in/us/stocks/cv) $342 million · Medical Devices
3. Crescent Capital BDC, Inc. $342 million
4. [FS Bancorp, Inc.](https://www.sectoralpha.in/us/stocks/fsbw) $341 million · Banks - Regional
5. [CS Disco, Inc.](https://www.sectoralpha.in/us/stocks/law) $340 million · Software - Application

## What else do people ask about Crescent Capital BDC? ### What were Crescent Capital BDC's latest quarterly results? Crescent Capital BDC, Inc. reported total income of $36.3 M and a net loss of $3.2 M for the Jun 2026 quarter. Income fell 15.5% and profit fell 121.6% compared with a year earlier. Earnings per share were −$0.09 (as of 3 November 2026). ### What is Crescent Capital BDC's market cap? Crescent Capital BDC, Inc.'s market capitalisation is $345 M at a stock price of $9.35. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Crescent Capital BDC performing? Crescent Capital BDC, Inc.'s latest readings are below. In its latest quarter, income fell 15.5% and profit fell 121.6% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 38 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Crescent Capital BDC's stock price go up? This page does not forecast Crescent Capital BDC, Inc.'s stock price. What it shows instead: the stock price is $9.35. Its P/BV of 0.5× is higher than 9% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Crescent Capital BDC in its business cycle? Crescent Capital BDC, Inc.'s FY25 net margin was 20.6%, against a 5-year range of 13.3% to 89.0%: the low end of its own range, which is often where recoveries start. The latest quarter was −8.9%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Crescent Capital BDC story? The main question: the P/BV is near the low end of its own history, higher than only 9% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Crescent Capital BDC a stock worth studying right now? What the numbers show: Crescent Capital BDC, Inc.'s P/BV is near the low end of its own history, higher than only 9% of past readings, and its quarterly results are still getting worse. The main open question: whether results start to improve. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.